Dudman, Daniel C.
Tauqeer, Fatima
Kaur, Moninder
Ritchey, Mary E.
Li, Hu
Lopez-Leon, Sandra http://orcid.org/0000-0001-7504-3441
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Innovative Medicines Initiative
Article History
Received: 2 March 2021
Revised: 23 March 2021
Accepted: 24 March 2021
First Online: 1 April 2021
Declarations
:
: DCD and SLL are employees of Novartis. MK is a former employee of Cognizant Technology Solutions on behalf of Novartis and a current employee of Barrington James Ltd on behalf of UCB. HL is a former employee of Eli Lilly and current employee of Gilead Science.
: This article does not contain any studies with human particpiants or animals performed by any of the authors.